ISSCHIGH SIGNALFINANCIAL10-K

ISSC shows dramatically conflicting financial metrics with substantially higher gross profit despite declining revenue, alongside meaningful increases in interest expense and asset base.

The substantial expansion in gross profit occurring simultaneously with revenue decline suggests either significant changes in product mix, cost structure improvements, or potential reporting inconsistencies that require careful scrutiny. The notable increase in interest expense coupled with growing assets indicates increased leverage and investment activity that may be driving the operational changes.

Comparing 2025-12-23 vs 2024-12-30View on EDGAR →
FINANCIAL ANALYSIS

ISSC presents a complex financial picture with revenue declining 17.5% while gross profit expanded substantially, suggesting either dramatic margin improvements or potential reporting issues. The company's balance sheet strengthened meaningfully with current assets growing 46% and stockholders' equity increasing 38%, though interest expense grew notably indicating increased borrowing. The divergent trends between declining top-line performance and expanding profitability metrics create an unusual pattern that warrants careful investor analysis.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
+84.1%
$937K$1.7M

Interest expense surged 84.1% — significant debt increase or rising rates materially impacting earnings.

Gross Profit
P&L
+56.3%
$25.9M$40.5M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Current Assets
Balance Sheet
+46.2%
$34.7M$50.7M

Current assets grew 46.2% — improving short-term liquidity or inventory/receivables build.

Stockholders Equity
Balance Sheet
+38.5%
$46.6M$64.6M

Equity base grew 38.5% — retained earnings accumulation or equity issuance strengthening the balance sheet.

SG&A Expense
P&L
+35.8%
$12.1M$16.4M

SG&A up 35.8% — significant increase in sales or administrative costs, monitor impact on operating leverage.

Total Assets
Balance Sheet
+25.5%
$82.4M$103.4M

Asset base grew 25.5% — expansion through organic growth, acquisitions, or capital deployment.

Revenue
P&L
-17.5%
$16.8M$13.9M

Revenue softened 17.5% — monitor whether this is cyclical or structural.

LANGUAGE CHANGES
NEW — 2025-12-23
PRIOR — 2024-12-30
ADDED
As of November 30, 2025, there were 17,752,354 outstanding shares of the registrant s common stock.
SUMMARY OF RISK FACTORS The following is a summary of the principal risks described in Part I, Item 1A.
We believe that the risks described in the Risk Factors section are material to investors, but other factors not presently known to us or that we currently believe are immaterial may also adversely affect us.
The following summary should not be considered an exhaustive summary of the material risks facing us, and it should be read in conjunction with the Risk Factors section and the other information contained in this Annual Report on Form 10-K.
If the Company fails to modify or improve its products in response to evolving industry standards and government regulations, its products could become obsolete rapidly.
+7 more — sign up free →
REMOVED
As of December 18, 2024, there were 17,536,418 outstanding shares of the registrant s common stock.
INTRODUCTION As used in this Annual Report on Form 10-K, unless expressly stated otherwise or the context otherwise requires, the terms ISSC or the Company , we , us and our , refers to Innovative Solutions Support and its subsidiaries.
In the fiscal year 2024 ended September 30, 2024, we reported net sales of $47.2 million, an increase of 35.6% on a year-over-year basis from $34.8 million in the fiscal year ended 2023, and net income of $7.0 increased 16.1% from $6.0 million in fiscal 2023.
At September 30, 2024, our backlog was $89.2 million compared with $13.5 million at September 30, 2023.
We expect to recognize approximately 65% of our backlog over the next 12 months and approximately 98% over the next 24 months as revenue, with the remainder recognized thereafter.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →